Availability of irinotecan in a second-line setting confers survival benefit to patients with advanced gastric cancer refractory to fluoropyrimidine-based regimens
| Image |  |
|---|---|
| Description | scientific article published on January 20, 2011 |
| Author/s |
author: Yoshimasa Kawazoe Kiyohiko Hatake |
| Publication date | January 20, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |